Gary Fischer
Analyst · Craig-Hallum. Your line is open
Thank you Terence and good afternoon everyone. Before we begin, I would again like to remind you that during the course of this conference call, including comments made in response to your questions, we will provide projections or make other forward-looking statements regarding, among other things, the future financial performance of the Company and our ability to control costs and improve efficiency, increase orders in succeeding quarters, improve our competitive position as the market improves, our ability to meet market demands for our products as well as other market conditions and trends including expected growth in the markets we serve. We wish to caution you that such statements deal with future events, are based upon management's current expectations and are subject to risks and uncertainties that could cause actual events or results to differ materially. These uncertainties and risks include, but are not limited to, overall conditions in the markets in which the Company competes, global financial conditions and uncertainties, market acceptance and demand for the Company's products and the impact of delays by our customers on the timing of sales of products. In addition to the factors that may be discussed in this call, we refer you to the Company's periodic reports filed with the Securities and Exchange Commission and available online by link from our website for additional information on risk factors that could cause actual results to differ materially from our current expectations. This conference call will be available on our website at axt.com through February 22, 2018. Also, before we begin, I want to note that shortly following the close of market today, we issued a press release reporting financial results for the fourth quarter of 2016 and the year ending 2016. This information is available on the Investor Relations portion of our website at axt.com. Thank you, and now turning to a review of our fourth quarter results total revenue in fourth quarter of 2016 was $20.3 million compared with $21.9 million in the third quarter of 2016. This is above the high-end of our expectations, which were $18.5 million to $19.5 million. In an effort to understand the underlying trends of our business, many of you have asked us to provide bit more granularity in the way we report revenue. So therefore beginning this quarter, we will also breakout revenue results for substrates and for raw materials. In the Q4 2016, revenue from substrate sales was $16.0 million compared with $17.0 million in the prior quarter. Revenue from our raw material joint ventures was $4.3 million in Q4 compared to $4.9 million in Q3. In the fourth quarter of 2016 revenue from North America was 6%, Asia Pacific was 71% and Europe was 23% of total revenue. In the fourth quarter we had no customer that generated more than 10% of revenue and the top five customers generated approximately 35% of total revenue reflecting, again, our diversification of both products and customers. Also for the entire year of 2016, we had no customer that generated 10% or more of revenue. Gross margin in the fourth quarter was 37.1%. This is an improvement from the prior quarter and is an result of the favorable mix and good progress in manufacturing efficiencies and yield improvements. Total OpEx in the fourth quarter was $5.2 million. This is up a little from the prior quarter but in general we have continued to keep OpEx relatively flat quarter to quarter. Total stock compensation expense was $298,000 for the fourth quarter of 2016, which $5,000 included in cost of revenues, $246,000 in SG&A and $47,000 in R&D. Operating profit for the fourth quarter of 2016 was $2.3 million compared with $2.7 million in the previous quarter. Interest and other income in the fourth quarter was a net charge of $274,000. This net number consists of four categories: one, interest earned of $106,000; two, foreign exchange loss of $95,000; three, equity accounting on our unconsolidated joint ventures, of a loss of $558,000; and four, other items equaling a gain of $274,000. For Q4 of 2016, we had a net profit of $2.2 million, which is $0.06 per share. This is north of our guidance, which was a range of profit of $0.02 to $0.04 per share. By comparison, we had a net profit of $2.2 million or $0.07 per share in the third quarter of 2016. Cash and cash equivalents and investments increased nicely in the quarter by $6.4 million moving us from a total of $47.3 million as of September 30, 2016 to $53.7 million as of December 31, 2016. Depreciation and amortization in the fourth quarter was $1.3 million and CapEx was about $900,000. Accounts receivables, net of reserves, were $14.5 million at December 31, 2016 compared with $18.4 million at September 30, 2016. Net inventory at December 31 was $40.2 million compared with $38.7 million in inventory at September 30. Ending inventory consisted of approximately 44% in raw materials, 50% in work in process and 6% in finished goods. The spread between the three buckets remains consistent. That covers the quarterly comparison. And allow me to briefly highlight the entire fiscal year, which is our calendar year. For the fiscal year, 2016 revenue was $81.3 million up from $77.5 million in fiscal year 2015. In 2016 revenue from substrate sales was $65.6 million compared with $58.2 million in 2015. Revenue from our raw material joint ventures was $15.7 million in 2016 compared with $19.3 million in 2015. Gross margin for the fiscal year 2016 improved meaningfully to 32.4% of revenue, up from 21.7% of revenue for fiscal year 2015. Our profitability in fiscal year 2016 also increased meaningfully. We achieved net income of $5.6 million or $0.17 per share compared with a net loss of $2.2 million or $0.07 per share for fiscal year 2015. That is a swing of $7.9 million year-to-year. Moving from a loss to a profit, which I guess to use non-financial terms is pretty cool. This concludes our financial review, I’ll now turn the call over to Dr. Morris Young for a review of our business.